Publicaciones en colaboración con investigadores/as de Hospital Universitario de Donostia (66)

2024

  1. Bacteria–Fungi Interactions in Multiple Sclerosis

    Microorganisms, Vol. 12, Núm. 5

  2. Microbiota modulation by teriflunomide therapy in people with multiple sclerosis: An observational case-control study

    Neurotherapeutics

2023

  1. Early biochemical analysis of COVID-19 patients helps severity prediction

    PLoS ONE, Vol. 18, Núm. 5 May

  2. Immune cell population and cytokine profiling suggest age dependent differences in the response to SARS-CoV-2 infection

    Frontiers in Aging, Vol. 4

2022

  1. Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis

    Frontiers in Immunology, Vol. 13

  2. Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis

    Journal of Neuroinflammation, Vol. 19, Núm. 1

2021

  1. Gut microbiota changes in experimental autoimmune encephalomyelitis and cuprizone mice models

    ACS Chemical Neuroscience, Vol. 12, Núm. 5, pp. 893-905

  2. O group is a protective factor for COVID19 in Basque population

    PLoS ONE, Vol. 16, Núm. 4 April

  3. Profiling of plasma extracellular vesicle transcriptome reveals that circrnas are prevalent and differ between multiple sclerosis patients and healthy controls

    Biomedicines, Vol. 9, Núm. 12

2020

  1. A new risk variant for multiple sclerosis at 11q23.3 locus is associated with expansion of CXCR5+ circulating regulatory T cells

    Journal of Clinical Medicine, Vol. 9, Núm. 3

  2. RNA-Seq profiling of leukocytes reveals a sex-dependent global circular RNA upregulation in multiple sclerosis and 6 candidate biomarkers

    Human Molecular Genetics, Vol. 29, Núm. 20, pp. 3361-3372

2019

  1. ABO blood group distributions in multiple sclerosis patients from Basque Country; O- as a protective factor

    Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 5, Núm. 4

  2. Liquid biopsy in glioblastoma: Opportunities, applications and challenges

    Cancers, Vol. 11, Núm. 7

  3. T cells and immune functions of plasma extracellular vesicles are differentially modulated from adults to centenarians

    Aging, Vol. 11, Núm. 22, pp. 10723-10741

2018

  1. Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidβ Are Strongly Associated With Healthy Aging in the Oldest Old

    Frontiers in Aging Neuroscience, Vol. 10

  2. Expression profiling analysis reveals key Microrna-mRNA interactions in early retinal degeneration in retinitis pigmentosa

    Investigative Ophthalmology and Visual Science, Vol. 59, Núm. 6, pp. 2381-2392

  3. The first dose of fingolimod affects circulating extracellular vesicles in multiple sclerosis patients

    International Journal of Molecular Sciences, Vol. 19, Núm. 8

  4. Transcriptomic integration of D4R and MOR signaling in the rat caudate putamen

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Circular RNA profiling reveals that circular RNAs from ANXA2 can be used as new biomarkers for multiple sclerosis

    Human Molecular Genetics, Vol. 26, Núm. 18, pp. 3564-3572

  2. Progressive changes in non-coding RNA profile in leucocytes with age

    Aging, Vol. 9, Núm. 4, pp. 1202-1218